TokyoTokyo Mon - Fri 10:00-18:00 +81 (368) 662-975
info@mountequitygroup.com

Biogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy

Mount Equity Group Tokyo, Japan > News > Markets > Biogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy